Psoralen and bergapten: In silico metabolism and toxicophoric analysis of drugs used to treat vitiligo

Journal of Pharmacy and Pharmaceutical Sciences

Volumn 12, Issue 3, 2009, Pages 378-387

  da Silva, Vinicius Barreto ^a   Kawano, Daniel Fábio ^a   Carvalho, Ivone ^a   da Conceição, Edemilson Cardoso ^b   de Freitas, Osvaldo ^b   da Silva, Carlos Henrique Tomich de Paula ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BERGAPTEN; PSORALEN; RESORCINOL; 5-METHOXYPSORALEN; DRUG DERIVATIVE; METHOXSALEN; PHOTOSENSITIZING AGENT;

ARTICLE; COMPUTER MODEL; CONTROLLED STUDY; DRUG DETERMINATION; DRUG METABOLISM; DRUG STRUCTURE; DRUG TRANSFORMATION; MATHEMATICAL COMPUTING; METABOLITE; STRUCTURE ACTIVITY RELATION; TOXICITY TESTING; TOXICOKINETICS; VITILIGO; ANIMAL; BIOLOGY; BIOTRANSFORMATION; COMPUTER SIMULATION; DRUG DEVELOPMENT; EXPERT SYSTEM; HUMAN; METABOLISM; METHODOLOGY;

ANIMALS; BIOTRANSFORMATION; COMPUTATIONAL BIOLOGY; COMPUTER SIMULATION; DRUG DISCOVERY; EXPERT SYSTEMS; FICUSIN; HUMANS; METHOXSALEN; PHOTOSENSITIZING AGENTS; VITILIGO;

EID: 77950363354     PISSN: None     EISSN: 14821826     Source Type: Journal    
DOI: 10.18433/J3W01D     Document Type: Article

References (36)

1. Sethi S, Mahajan BB, Gupta RR and Ohri A. Comparative evaluation of the therapeutic efficacy of dermabrasion, dermabrasion combined with topical 5% 5-fluorouracil cream, and dermabrasion combined with topical placentrex gel in localized stable vitiligo. Int J Dermatol, 46(8):875-879, 2007.
2. Steiner D, Bedin V, Moraes MB, Villas RT and Steiner T. Vitiligo. An Bras Dermatol, 79(3):335-351, 2004.
3. Hernández NF, Davison GP and Sánchez GM. Vitíligo: actualización bibliográfica. Lat Am J Pharm, 27(6):938-945, 2008.
4. Dewick PM. The shikimate pathway: aromatic amino acids and phenylpropanoids, in Dewick PM (ed) Medicinal natural products: a biosynthetic approach. 2nd ed. John Wiley & Sons: New York, NY, pp 121-166, 2002.
5. Pathak MA, Daniels F and Fitzpatrick TB. The presently known distribution of furocoumarins (psoralens) in plants. J Invest Dermatol, 39:225-239, 1962.
6. Mckeon JJ. PUVA for psoriasis. Am Pharm, 9:530-532, 1981.
7. Rocha MS, Viana NB and Mesquita ON. DNA-psoralen interaction: a single molecule experiment. J Chem Phys, 121(19):9679-9683, 2004.
8. Luftl M, Rocken M, Plewig G and Degitz K. PUVA inhibits DNA replication, but not gene transcription at nonlethal dosages. J Invest Dermatol, 111:399-405, 1998.
9. Spielmann HP, Dwyer TJ, Sastry SS, Hearst JE and Wemmer DE. DNA structural reorganization upon conversion of a psoralen furan-side monoadduct to an interstrand crosslink: implications for DNA repair. Proc Natl Acad Sci, 92:2345-2349, 1995.
10. Diawara MM, Chavez KJ, Hoyer PB, Williams DE, Dorsch J, Kulkosky P and Franklin MR. A novel group of ovarian toxicants, the psoralens. J Biochem Mol Toxicol, 13:195-203, 1999.
11. McKenna KE. Iatrogenic skin cancer: induction by psoralen/ultraviolet A and immunosuppression of organ transplant recipients. Photodermatol Photo, 20:289-296, 2004.
12. Kreimer-Erlacher H, Seidl H, Back B, Cerroni L, Kerl H and Wolf P. High frequency of ultraviolet mutations at the INK4a-ARF locus in squamous cell carcinomas from psoralenplus-ultraviolet-A-treated psoriasis patients. J Invest Dermatol, 120:676-682, 2003.
13. Diawara MM and Trumble JT. Linear furanocoumarins, in D'Mello JPF (ed) Handbook of plant and fungal toxicants. 1st ed. CRC Press: New York, NY, pp 175-188, 1997.
14. Forlot P. Toxicological and pharmacological properties of bergapten. Essenze Deriv Agrum, 70(3):147-153, 2000.
15. Pang Z, Wang B and Qi Y. Study on the pharmacokinetics of psoralen and isopsoralen by fluorometry. Chinese J Anal Chem, 29(2):146-149, 2001.
16. Lake BG. Coumarin metabolism, toxicity and carcinogenicity: relevance for human risk assessment. Food Chem Toxicol, 37:423-453, 1999.
17. Hadidi H, Zahlsen K, Idle JR and Cholerton S. A single amino acid substitution (Leu160His) in cytochrome P450CYP2A6 causes switching from 7-hydroxylation to 3-hydroxylation of coumarin. Food Chem Toxicol, 35(9):903-907, 1997.
18. Fentem JH and Fry JR. Species differences in the metabolism and hepatotoxicity of coumarins. Comp Biochem Phys C, 104(1):1-8, 1993.
19. Meteor Version 10.0.2 (2007). Lhasa Ltd, Leeds, UK.
20. Derek for Windows Version 10.0.2 (2007). Lhasa Ltd, Leeds, UK.
21. Sanderson DM and Earnshaw CG. Computer prediction of possible toxic action from chemical structure; The DEREK system. Hum Exp Toxicol, 10:261-273, 1991.
22. Ridings JE, Barratt MD, Cary R, Earnshaw CG, Eggington CE, Ellis MK, Judson PN, Langowski JJ, Marchant CA, Payne MP, Watson WP and Yih TD. Computer prediction of possible toxic action from chemical structure: an update on the DEREK system. Toxicology, 106:267-279, 1996.
23. Greene N, Judson PN, Langowski JJ and Marchant CA. Knowledge-based expert systems for toxicity and metabolism prediction: DEREK, StAR and METEOR. SAR QSAR Environ Res, 10:299-314, 1999.
24. Testa B, Balmat A, Anthony L, and Philip J. Predicting drug metabolism: an evaluation of the expert system METEOR. Chem Biodivers, 2(7):872-85, 2005.
25. th ed. Lippincott Williams & Wilkins: New York, NY, pp 253-326, 2008.
26. Hine C, Rowe VK, White ER, Darmer KI and Youngblood GT. Epoxy compounds, in Clayton GD and Clayton FE (eds) Patty's Industrial Hygiene and Toxicology. 3rd ed. John Wiley: New York, NY, pp 2141-2257, 1981.
27. Peterson LA, Naruko KC and Predecki D. A reactive metabolite of furan, cis-2-butene-1,4-dial, is mutagenic in the Ames assay. Chem Res Toxicol, 13:531-34, 2000.
28. Chen LJ, Hecht SS and Peterson LA. Identification of cis-2-butene-1,4-dial as a microsomal metabolite of furan. Chem Res Toxicol, 8(7):903-906, 1995.
29. Burka LT, Washburn KD and Irwin RD. Disposition of [14C]furan in the male F344 rat. J Toxicol Environ Health, 34(2):245-257, 1991.
30. Byrns MC, Predecki DP and Peterson LA. Characterization of nucleoside adducts of cis-2-butene-1,4-dial, a reactive metabolite of furan. Chem Res Toxicol, 15(3):373-79, 2002.
31. Kaidbey KH and Kligman AM. Photosensitization by coumarin derivatives. Arch Dermatol, 117:258-263, 1981.
32. Barratt MD and Brown KR. Photochemical binding of photoallergens to human serum albumin: a simple in vitro method for screening potential photoallergens. Toxicol Lett, 24:1-6, 1985.
33. Kato S, Seki T, Katsumura Y, Kobayashi T, Komatsu K and Fukushima S. Mechanism for 6-methylcoumarin photoallergenicity. Toxicol Appl Pharmacol, 81(2):295-301, 1985.
34. Delahanty JN, Evans JC, Rowlands CC and Barratt MD. An electron spin resonance study of the free radicals formed on ultraviolet irradiation of the photoallergens fentichlor and bithionol. J Chem Soc Faraday Trans I, 83:135-139, 1987.
35. Barratt MD, Basketter DA and Roberts DW. Skin sensitization structure-activity relationships for phenyl benzoates. Toxicol in Vitro, 8:823-826, 1994.
36. Barratt M. D and Basketter DA. Possible origin of the skin sensitization potential of isoeugenol and related compounds: (I) preliminary studies of potential reaction mechanisms. Contact Derm, 27:98-104, 1992.